Lymphocyte Predominant Hodgkin's Lymphoma (LPHL)
This information was originally presented on September 21, 2013, at the NCCN 8th Annual Congress: Hematologic Malignancies™ held in New York, New York.
Target Audience
This activity is designed to meet the educational needs of hematologists, oncologists, nurses, pharmacists, and other health care professionals who manage patients with hematologic malignancies.
Learning Objectives
Following this activity, participants should be able to:
- Summarize the current treatment options and the role of monoclonal antibodies in the management of patients with LPHL
Ranjana H. Advani, MD
Stanford Cancer Institute
Available Credit
- 0.50 Participation
- 0.40 Nurse
- 0.50 Pharmacist
- 0.50 Physician
Price
Cost:
$0.00
Required Hardware/software
To access this activity, users will need:
- A device with an Internet connection and sound playback capability
- Adobe Flash Player and/or an HTML5 capable browser for video or audio playback
- Adobe Reader for certificate viewing/printing